enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Both private equity firms who control a good portion of enGene Holdings Inc. (NASDAQ:ENGN) along with institutions must be dismayed after last week's 16% decrease [Yahoo! Finance]
enGene (NASDAQ:ENGN) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. [Yahoo! Finance]
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.